Lymphoma Coalition is delighted to announce its participation in the 49th Annual European Society for Blood and Marrow Transplantation (EBMT) meeting, taking place this weekend in Paris France. Presenting the poster, “P877: A Cross-Sectional Study Examining Potential Demographic Barriers to Receiving Information on Clinical Trials in Relapsed/Refractory Patients Who Have Received Stem Cell Transplants (SCT).
During the meeting, Lymphoma Coalition’s CEO, Lorna Warwick, will speak on Sunday at 12:30 CEST during the session “Nurses Challenges in 2023: Understanding Quality of Life.”
Furthermore, Natacha Bolanos, Head of Membership Alliances at Lymphoma Coalition, will present at the Multi-Stakeholder Forum on Innovative Cellular Therapies I – Access to Innovative Therapies on Wednesday, April 26, from 08:30 to 09:45 in Room 143.
We are also excited to share that Patient, Family, and Donor Day (PFDD) at the EBMT Annual Meeting will occur on Sunday, April 23, 2023, and will be live-streamed through the congress virtual platform. This event aims to enhance communication between EBMT professionals and patients while exploring both scientific trends and the unique bond often formed between clinical BMT personnel, patients, and their families.
Natacha Bolanos and Guy Bouguet, President of France Lymphome Espoir and Treasurer on the LC Board of Directors, will chair the Patient Advocacy Sessions. They have been instrumental in organizing the PFDD.
We invite everyone to attend this exceptional event, with free registration available
Additionally, two Patient Advocacy Sessions will take place on Monday, as integral part of the scientific program. If you want to join and haven’t applied yet, send your CV and a letter of intent to secretariat@ebmt.org. Once 30 applications have been received and approved, no further applications will be accepted.
We hope to see you there!